Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic

Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic

Introduction: OnabotulinumtoxinA (BT-A) is a preventive treatment for chronic migraine (CM), which needs to be administered regularly by a trained clinician every 3 months. The spread of the severe acute respiratory syndrome coronavirus-2 pandemic has forced many patients to momentarily stop the sch...

Full description

Bibliographic Details
Main Authors: Carlo Baraldi, Raffaele Ornello, Valentina Favoni, Simona Sacco, Valeria Caponnetto, Giulia Pierangeli, Luca Pani, Sabina Cevoli, Simona Guerzoni
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Neurology
Subjects:
chronic migraine
severe acute respiratory syndrome coronavirus-2 pandemic
medication overuse headache
onabotulinumtoxinA
migraine frequency
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.647995/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2021.647995/full

Similar Items